Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pimasertib hydrochloride by Day One Biopharmaceuticals for Solid Tumor: Likelihood of Approval
Pimasertib hydrochloride is under clinical development by Day One Biopharmaceuticals and currently in Phase II for Solid Tumor. According to...